Manufacturing Industry
Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis
Chemistry and Industry, August 11, 2008 by Neil Eisberg
Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis. The offer of CZK10S0/share, making Zentiva worth $2.69bn, is said to undervalue the company, and follows an even lower offer by PPF.
Sanofi-aventis already owns just under 25% of Zentiva through the acquisition of a $518m holding in 2006.
Most Recent Technology Articles
- INTERVIEW WITH BEN BUTTERS, DIRECTOR OF EUROPEAN AFFAIRS AT EUROCHAMBRES : "A PERFECT ROAD MAP FOR EU CLUSTERS DOES NOT EXIST".
- AGENDA.(Brief article)(Conference notes)
- FIGHT AGAINST INTERNET PIRACY.
- INTERNET : AUTHORS' SOCIETIES URGE ACTION AGAINST PIRACY.
- TELECOMMUNICATIONS : BUSINESSEUROPE HOSTILE TO FURTHER CONTRACTUAL OBLIGATIONS.(Brief article)
Most Recent Technology Publications
Most Popular Technology Articles
- 3G: naughty or nice? PhoneErotica.com generates over 300 million hits per month, and rings up more minutes of use per month than MSN
- Business process re-engineering in the small firm: A case study
- Performance analysis of shell and tube heat exchanger using miscible system
- What is precision air conditioning and why is it necessary?
- Optimizing of Trichoderma viride cultivation in submerged state fermentation


